{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T20:26:02Z","timestamp":1761423962830,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017596","name":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejon.2023.102338","type":"journal-article","created":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:23:14Z","timestamp":1683480194000},"page":"102338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Patient\u2019 and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0713-2623","authenticated-orcid":false,"given":"Caroline","family":"Steigenberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-9641","authenticated-orcid":false,"given":"Petra","family":"Schnell-Inderst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Flatscher-Th\u00f6ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa-Maria","family":"Plank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2023.102338_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000337474","article-title":"Quality of life of breast cancer patients during mistletoe therapy: a qualitative study. [Lebensqualit\u00e4t von Brustkrebspatientinnen w\u00e4hrend der Misteltherapie: eine qualitative Studie.]","volume":"24","author":"Brandenberger","year":"2012","journal-title":"Schweiz. Z. Ganzheitsmed."},{"year":"2015","series-title":"Grey Matters: a Practical Tool for Searching Health-Related Grey Literature","key":"10.1016\/j.ejon.2023.102338_bib2"},{"key":"10.1016\/j.ejon.2023.102338_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jclinepi.2017.11.028","article-title":"Cochrane Qualitative and Implementation Methods Group guidance series-paper 4: methods for assessing evidence on intervention implementation","volume":"97","author":"Cargo","year":"2018","journal-title":"J. Clin. Epidemiol."},{"year":"2018","series-title":"CASP Cohort Study Checklist","author":"CASP","key":"10.1016\/j.ejon.2023.102338_bib4"},{"year":"2018","series-title":"CASP Qualitative Checklist. Critical Appraisal Skills Programme","author":"CASP","key":"10.1016\/j.ejon.2023.102338_bib5"},{"year":"2018","series-title":"Mapping of HTA National Organisations, Programmes and Processes in EU and Norway","author":"Chamova","key":"10.1016\/j.ejon.2023.102338_bib8"},{"key":"10.1016\/j.ejon.2023.102338_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12906-018-2325-3","article-title":"Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy","volume":"18","author":"Drozdoff","year":"2018","journal-title":"BMC Compl. Alternative Med."},{"year":"2016","series-title":"HTA Core Model Version 3.0 for the Full Assessment of Diagnostic Technologies, Medical and Surgical Interventions, Pharmaceuticals and Screening Technologies","author":"EUnetHTA","key":"10.1016\/j.ejon.2023.102338_bib7"},{"key":"10.1016\/j.ejon.2023.102338_bib9","first-page":"1277","article-title":"Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies","volume":"15","author":"Fasching","year":"2007","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2023.102338_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00404-017-4348-2","article-title":"Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network","volume":"295","author":"Fremd","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejon.2023.102338_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00432-018-02838-3","article-title":"Mistletoe in oncological treatment: a systematic review: Part 2: quality of life and toxicity of cancer treatment","volume":"145","author":"Freuding","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejon.2023.102338_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00432-018-02837-4","article-title":"Mistletoe in oncological treatment: a systematic review: Part 1: survival and safety","volume":"145","author":"Freuding","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"year":"2019","series-title":"Deaths in Germany, 2007 - 2017, by Cause of Death: Malignant Neoplasms Total and ICD-10 C-50 (BN of Mammary Gland)","author":"German Federal Statistical Office (DESTATIS)","key":"10.1016\/j.ejon.2023.102338_bib13"},{"key":"10.1016\/j.ejon.2023.102338_bib14","first-page":"194","article-title":"Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment","volume":"67","author":"Greenlee","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejon.2023.102338_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00404-020-05880-0","article-title":"Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany","volume":"303","author":"Grimm","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejon.2023.102338_bib16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00404-020-05869-9","article-title":"Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany","volume":"303","author":"Grimm","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejon.2023.102338_bib17","first-page":"215","article-title":"Beweggruende von Krebspatienten fuer und gegen die Inanspruchnahme der Misteltherapie","volume":"23","author":"Gschwendtner","year":"2016","journal-title":"Forschende Komplement\u00e4rmed."},{"key":"10.1016\/j.ejon.2023.102338_bib18","article-title":"Mistletoe therapy in oncology","author":"Horneber","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejon.2023.102338_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000360381","article-title":"Online survey of patients with breast cancer on complementary and alternative medicine","volume":"9","author":"Huebner","year":"2014","journal-title":"Breast Care"},{"key":"10.1016\/j.ejon.2023.102338_bib20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00432-021-03579-6","article-title":"Cancer patients' perspective on shared decision-making and decision aids in oncology","volume":"147","author":"Josfeld","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejon.2023.102338_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2001-10461","article-title":"Opinions of gynecologists on unconventional and complementary cancer therapy (UCT)","volume":"61","author":"Kalder","year":"2001","journal-title":"Geburtshilfe Frauenheilkd"},{"author":"Kienle","key":"10.1016\/j.ejon.2023.102338_bib22"},{"key":"10.1016\/j.ejon.2023.102338_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1534735416640091","article-title":"Individualized integrative cancer care in anthroposophic medicine: a qualitative study of the concepts and procedures of expert doctors","volume":"15","author":"Kienle","year":"2016","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ejon.2023.102338_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4628287","article-title":"Intravenous mistletoe treatment in integrative cancer care: a qualitative study exploring the procedures, concepts, and observations of expert doctors","author":"Kienle","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejon.2023.102338_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00404-017-4420-y","article-title":"Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey","volume":"296","author":"Klein","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejon.2023.102338_bib26","unstructured":"KOKON & DGHO, 2015. Onkopedia Leitlinien. Mistel (Viscum album). Publisher: Competence network complementary medicine in oncology (KOKON) and German society for haematology and medical oncology (DGHO).https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/mistel-viscum-album\/@@guideline\/html\/index.html. (Accessed 28 March 2022)."},{"key":"10.1016\/j.ejon.2023.102338_bib27","first-page":"68","article-title":"Metaphorical Aspects of Mistletoe Therapy in Patients' Experiences - a Qualitative Study [Metaphorische Aspekte der Misteltherapie im Patientenerleben - eine qualitative Studie]","volume":"8","author":"Konitzer","year":"2001","journal-title":"Forsch Komplementarmed Klass Naturheilkd"},{"key":"10.1016\/j.ejon.2023.102338_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12906-020-03013-3","article-title":"Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis","volume":"20","author":"Loef","year":"2020","journal-title":"BMC Complement Med Ther"},{"year":"2010","series-title":"Qualitative Content Analysis: Principles and Techniques [Qualitative Inhaltsanalyse: Grundlagen und Techniken]","author":"Mayring","key":"10.1016\/j.ejon.2023.102338_bib29"},{"year":"2015","series-title":"Qualitative Content Analysis: Principles and Techniques [Qualitative Inhaltsanalyse: Grundlagen und Techniken]","author":"Mayring","key":"10.1016\/j.ejon.2023.102338_bib30"},{"issue":"Suppl. l","key":"10.1016\/j.ejon.2023.102338_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1188\/14.CJON.S3.38-58","article-title":"Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment","volume":"18","author":"Mitchell","year":"2014","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ejon.2023.102338_bib32","first-page":"260","article-title":"Complementary and alternative medicine use in breast cancer patients in Europe","volume":"14","author":"Molassiotis","year":"2006","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2023.102338_bib33","first-page":"267","article-title":"Use of alternative\/complementary therapy in breast cancer patients - a psychological perspective","volume":"9","author":"Moschen","year":"2001","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2023.102338_bib34","first-page":"1222","article-title":"Oncologic mistletoe therapy - physicians use and estimated efficiency","volume":"125","author":"Muenstedt","year":"2000","journal-title":"DMW (Dtsch. Med. Wochenschr.)"},{"year":"2020","series-title":"Health Information: European Mistletoe. National Center for Complementary and Integrative Health","key":"10.1016\/j.ejon.2023.102338_bib35"},{"year":"2021","series-title":"Complementary, Alternative, or Integrative Health: What's in a Name? National Center for Complementary and Integrative Health","key":"10.1016\/j.ejon.2023.102338_bib36"},{"key":"10.1016\/j.ejon.2023.102338_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jclinepi.2017.06.020","article-title":"Cochrane Qualitative and Implementation Methods Group guidance series-paper 3: methods for assessing methodological limitations, data extraction and synthesis, and confidence in synthesized qualitative findings","volume":"97","author":"Noyes","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejon.2023.102338_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jval.2020.05.001","article-title":"Announcing the new definition of health technology assessment","volume":"23","author":"O'Rourke","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.ejon.2023.102338_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420917211","article-title":"Impact of oncological therapy and viscum album L treatment on cancer-related fatigue and internal coherence in nonmetastasized breast cancer patients","volume":"19","author":"Oei","year":"2020","journal-title":"Integr. Cancer Ther."},{"article-title":"S3 guideline on early detection, diagnosis, treatment, and aftercare of mamma carcinoma [S3-Leitlinie Frueherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms]. Version 4.4, 2021, AWMF Registry number.: 032-045OL","year":"2020","series-title":"Oncology Guideline Program of the Association of the Scientific Medical Societies in Germany (AWMF), the German Cancer Society (DKG), and the German Cancer Aid (DKH)","key":"10.1016\/j.ejon.2023.102338_bib40"},{"article-title":"S3-Guideline complementary medicine in the treatment of oncological patients [S3-Leitlinie Komplement\u00e4rmedizin in der Behandlung onkologischer PatientInnen]","year":"2021","series-title":"Oncology Guideline Program of the Association of the Scientific Medical Societies in Germany (AWMF), the German Cancer Society (DKG), and the German Cancer Aid (DKH","key":"10.1016\/j.ejon.2023.102338_bib41"},{"year":"2019","series-title":"Cancer in Germany for 2015\/16 [Krebs in Deutschland Fuer 2015\/16]","key":"10.1016\/j.ejon.2023.102338_bib42"},{"key":"10.1016\/j.ejon.2023.102338_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000478655","article-title":"Implementation of an integrative oncological concept in the daily care of a German certified breast cancer center","volume":"25","author":"Schad","year":"2018","journal-title":"Complement. Med. Res."},{"key":"10.1016\/j.ejon.2023.102338_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420963780","article-title":"Analysis of changes in cancer-related fatigue of breast cancer patients receiving an integrative medicine program","volume":"19","author":"Schad","year":"2020","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ejon.2023.102338_bib45","series-title":"Federal Institute for Drugs and Medicinal Devices (BfArM)","article-title":"Additional treatment with mistletoe extracts in patients with breast cancer compared to conventional cancer therapy alone. Efficacy and safety, costs and cost-effectiveness, patient aspects, social aspects and ethical evaluation","author":"Schnell-Inderst","year":"2021"},{"key":"10.1016\/j.ejon.2023.102338_bib46","article-title":"Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone \u2013 efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment","author":"Schnell-Inderst","year":"2022","journal-title":"GMS German Medical Science \u2014 an Interdisciplinary Journal"},{"key":"10.1016\/j.ejon.2023.102338_bib47","first-page":"304","article-title":"Use of complementary\/alternative therapies in patients with breast cancer. [Anwendung komplement\u00e4rer\/alternativer Therapiemassnahmen bei Patientinnen mit Brustkrebs]","volume":"10","author":"Schoenekaes","year":"2003","journal-title":"Forschende Komplement\u00e4rmed. Klassische Naturheilkunde"},{"key":"10.1016\/j.ejon.2023.102338_bib48","first-page":"10","article-title":"Unproven methods in cancer: a worldwide problem","volume":"8","author":"Schraub","year":"2000","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2023.102338_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/ajco.12490","article-title":"Complementary and alternative medicine use by patients receiving curative-intent chemotherapy","volume":"12","author":"Smith","year":"2016","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.ejon.2023.102338_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1534735406298143","article-title":"A critical review of complementary therapies for cancer-related fatigue","volume":"6","author":"Sood","year":"2007","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ejon.2023.102338_bib51","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.ejca.2012.04.021","article-title":"Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study","volume":"48","author":"Tautz","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejon.2023.102338_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-153","article-title":"Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors","volume":"13","author":"Templeton","year":"2013","journal-title":"BMC Cancer"},{"first-page":"64","year":"2016","series-title":"EndNote","key":"10.1016\/j.ejon.2023.102338_bib53"},{"key":"10.1016\/j.ejon.2023.102338_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2005-862589","volume":"37","author":"Theobald","year":"2005","journal-title":"Deutsche Zeitschrift fur Onkologie"},{"key":"10.1016\/j.ejon.2023.102338_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ejon.2023.102338_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ctim.2018.03.012","article-title":"Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital","volume":"40","author":"Thronicke","year":"2018","journal-title":"Compl. Ther. Med."},{"year":"2019","series-title":"MAXQDA 2020, Computer Program","key":"10.1016\/j.ejon.2023.102338_bib57"},{"key":"10.1016\/j.ejon.2023.102338_bib58","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1188\/10.CJON.E45-E55","article-title":"Complementary and alternative medicine use among women with breast cancer: a systematic review","volume":"14","author":"Wanchai","year":"2010","journal-title":"Clin. J. Oncol. Nurs."}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388923000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388923000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T20:24:07Z","timestamp":1761423847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388923000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":58,"alternative-id":["S1462388923000728"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2023.102338","relation":{},"ISSN":["1462-3889"],"issn-type":[{"type":"print","value":"1462-3889"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient\u2019 and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2023.102338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102338"}}